NEW World Medical, Inc.
USPTO PatentsView assignee record - 28 granted patents across 4 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, NEW ranks #11,021 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 4 technology areas.
- #11,021
- of 49,997 US assignees by volume
- Top 49%
- by Innovation Score (35.5/100)
- 17.0
- avg claims per patent
- +1150%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R11021 · US Corporation #11,021 · 28 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 28 grants
- UPPER-Q #11,021/49,997
- PHOTO-FINISH Mylan Laboratories
- CPC-NARROW A61F · 4 areas
- INNOV-THIN 35.5/100
- CLAIMS-RICH 17.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +1150% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Mylan Laboratories Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How NEW’s 35.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around NEW
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Delta Tooling · near
Delta Tooling · near
36 score
- NEW World Medical · this assignee
NEW World Medical · this assignee
36 score
- Tangible Play · near
Tangible Play · near
36 score
- Vanguard Packaging · near
Vanguard Packaging · near
36 score
- VTV Therapeutics · near
VTV Therapeutics · near
36 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows NEW's Innovation Score is 35.5/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for NEW?
Each dot is one of NEW’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). NEW’s own 17.0 claims/patent is ABOVE the 10.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where NEW's grants concentrate
NEW World Medical, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 92.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (7 grants) versus a trough of 1 in 2018. By volume, NEW sits between Mylan Laboratories Limited and NSE Products, Inc..
NEW's three-year grant acceleration
NEW World Medical, Inc. shows 13 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at NEW's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Mylan Laboratories
Mylan Laboratories Limited
28 patents
- Nanjing Forestry…
Nanjing Forestry University
28 patents
- National Christma…
National Christmas Products LLC
28 patents
- Neogen
Neogen Corporation
28 patents
- Nexter Munitions
Nexter Munitions
28 patents
- Nippon Filcon
Nippon Filcon Co., Ltd.
28 patents
- Nissin Chemical I…
Nissin Chemical Industry Co., Ltd.
28 patents
- NSE Products
NSE Products, Inc.
28 patents
- NEW World Medical ◀
NEW World Medical, Inc.
28 patents
What this shows NEW holds 28 patents at rank #11,015, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near NEW
By rank, the assignees closest to #11,015 in granted patent volume.
- Mylan Laboratories Limited #11,011 · 28 patents
- Nanjing Forestry University #11,012 · 28 patents
- National Christmas Products LLC #11,013 · 28 patents
- Neogen Corporation #11,014 · 28 patents
- Nexter Munitions #11,016 · 28 patents
- Nippon Filcon Co., Ltd. #11,017 · 28 patents
- Nissin Chemical Industry Co., Ltd. #11,018 · 28 patents
- NSE Products, Inc. #11,019 · 28 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in NEW's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for NEW, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), NEW ranks #250 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (36 here).
NEW's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
36 Top 49% higher than 51% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 3.6% |
| 2019 | 1 | 3.6% |
| 2020 | 7 | 25.0% |
| 2021 | 5 | 17.9% |
| 2022 | 4 | 14.3% |
| 2023 | 3 | 10.7% |
| 2024 | 6 | 21.4% |
| 2025partial year | 1 | 3.6% |
Which technologies does NEW World Medical, Inc. patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
NEW World Medical, Inc.'s patent record in context - here's where to go next.
- NEW World Medical, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 92.9% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #11,021 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare NEW World Medical, Inc. against Mylan Laboratories Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 35.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.